The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
. Premature Age-Related Comorbidities Among HIV-Infected Persons Compared with the General Population.
Abstract
BACKGROUND: Human immunodeficiency virus (HIV)-infected patients may have a greater risk of noninfectious comorbidities (NICMs) compared with the general population. We assessed the prevalence and risk factors for NICMs in a large cohort of HIV-infected adults and compared these findings with data from matched control subjects. METHODS: We performed a case-control study involving antiretroviral therapy (ART)-experienced HIV-infected patients treated at Modena University, Italy, from 2002 through 2009. These patients were compared with age-, sex-, and race-matched adults (control subjects) from the general population included in the CINECA ARNO database. NICMs included cardiovascular disease, hypertension, diabetes mellitus, bone fractures, and renal failure. Polypathology (Pp) was defined as the concurrent presence of ≥2 NICMs. Logistic regression models were constructed to evaluate associated predictors of NICMs and Pp. RESULTS: There were 2854 patients and 8562 control subjects. The mean age was 46 years, and 37% were women. Individual NICM and Pp prevalences in each age stratum were higher among patients than among controls (all P <.001). Pp prevalence among patients aged 41-50 years was similar to that among controls aged 51-60 years (P value was not statistically significant); diabetes mellitus, cardiovascular disease, bone fractures, and renal failure were statistically independent after adjustment for sex, age, and hypertension. Logistic regression models showed that independent predictors of Pp in the overall cohort were (all P < .001) age (odds ratio [OR], 1.11), male sex (OR, 1.77), nadir CD4 cell count <200 cells/μL (OR, 4.46), and ART exposure (OR, 1.01). CONCLUSIONS: Specific age-related NICMs and Pp were more common among HIV-infected patients than in the general population. The prevalence of Pp in HIV-infected persons anticipated Pp prevalence observed in the general population among persons who were 10 years older, and HIV-specific cofactors (lower nadir CD4 cell count and more prolonged ART exposure) were identified as risk factors. These data support the need for earlier screening for NICMs in HIV-infected patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Self-citationCD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Mortality in the Highly Active Antiretroviral Therapy Era
Palella, F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233310.90484.16 · Cited by 1,362
Self-citationHIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus
The Data Collection on Adverse Events of Anti-HIV Drugs Study Group* (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,115
Introduction to Graphical Modelling
Edwards, D. (2000) · Springer texts in statistics · doi:10.1007/978-1-4612-0493-0 · Cited by 809
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.
Deeks, S. G., & Phillips, A. N. (2009) · BMJ · doi:10.1136/bmj.a3172 · Cited by 704
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Deeks, 2009, Topics in HIV medicine : a publication of the International AIDS Society, USA, 17, 118
- Justice, 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA, 14, 159
- 2008, Annals of nutrition & metabolism, 52, 6, 10.1159/000115340 · DOI
- 2010, Research initiative, treatment action : RITA, 15, 29
Cited by
Sorted by citations
Items 701–800 of 1,000
Nutrition counselling and clinical outcomes in HIV: A systematic review and meta‐analysis
Okusanya, T. R., Okoka, E. M., Kuyebi, M. A., Oyadiran, O. T., Kowe, T., Noor, R. A., Omotayo, M. O., & Abioye, A. I. (2023) · HIV Medicine · doi:10.1111/hiv.13603 · Cited by 10
Advanced HIV disease in East Africa and Nigeria, in The African Cohort Study
Oboho, I., Esber, A. L., Dear, N. F., Paulin, H. N., Iroezindu, M. O., Bahemana, E., Kibuuka, H. N., Owuoth, J., Maswai, J. K., Shah, N., et al. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003392 · Cited by 10
Aging on antiretrovirals: reviewing the need for pharmacologic data in elderly people with HIV
King, E. M., Tkachuk, S., & Tseng, A. L.-I. (2024) · AIDS · doi:10.1097/qad.0000000000003973 · Cited by 10
Voriconazole and Atazanavir: A CYP2C19-Dependent Manageable Drug–Drug Interaction
Calcagno, A., Baietto, L., Pagani, N., Simiele, M., Audagnotto, S., D’Avolio, A., Rosa, F. G. D., Perri, G. D., & Bonora, S. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.92 · Cited by 10
Cocaine use may induce telomere shortening in individuals with HIV infection
Lai, S., Heaphy, C. M., Rizzo, A. J., Celentano, D. D., Gerstenblith, G., Li, J., Moore, R. D., Treisman, G. J., Chen, S., Foster, P., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.015 · Cited by 10
Dolutegravir-rilpivirine: first 2-drug regimen for HIV-positive adults
Properzi, M., Magro, P., Castelli, F., & Quirós-Roldán, E. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1544491 · Cited by 10
Age of HIV Acquisition Affects the Risk of Multi-Morbidity After 25 Years of Infection Exposure
Guaraldi, G., Malagoli, A., Milić, J., Pintassilgo, I., Rossi, E., Riva, N., Franconi, I., Santoro, A., Sorin, P., Streinu‐Cercel, A., et al. (2019) · The Journal of Frailty & Aging · doi:10.14283/jfa.2019.6 · Cited by 10
Self-citationNovel Mechanism of Microvesicle Regulation by the Antiviral Protein Tetherin During HIV Infection
Weber, E. A., Singh, M. V., Singh, V. B., Jackson, J. W., Ture, S. K., Suwunnakorn, S., Morrell, C. N., & Maggirwar, S. B. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.015998 · Cited by 10
Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH)
Gutiérrez, M. D. M., Mur, I., Mateo, G. M., Vidal, F., & Domingo, P. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1887140 · Cited by 10
Masiá, M., Padilla, S., Moreno, S., Barber, X., Iribarren, J. A., Romero, J. D., Gómez-Sirvent, J. L., Rivero, M., Vidal, F., Campins, A. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184329 · Cited by 10
Wang, R., Shlipak, M. G., Ix, J. H., Brown, T. T., Jacobson, L. P., Palella, F. J., Lake, J. E., Koletar, S. L., Semba, R. D., & Estrella, M. M. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001868 · Cited by 10
Self-citationFrancis‐Morris, A., Mackie, N., Eliahoo, J., Ramzan, F., Fidler, S. J., & Pollock, K. M. (2019) · HIV Medicine · doi:10.1111/hiv.12800 · Cited by 11
Levy, M. E., Greenberg, A. E., Magnus, M., Younes, N., Castel, A. D., Subramanian, T., Binkley, J., Taylor, R., Rayeed, N., Hou, Q., et al. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0145 · Cited by 10
Diallo, I., Méda, N., Ouédraogo, S., Poda, A., Héma, A., Sagna, Y., Sawadogo, L. M., Drabo, Y. J., & Ouedraogo, D. (2017) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325957417709088 · Cited by 10
HIV infection as a permanent, acquired risk factor for VTE
Bibas, M., Biava, G., & Antinori, A. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.211-c1 · Cited by 10
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVPreprint
Alrubayyi, A., Gea‐Mallorquí, E., Touizer, E., Hameiri‐Bowen, D., Kopycinski, J. T., Charlton, B. G., Fisher-Pearson, N., Muir, L., Rosa, A., Roustan, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-309746/v1 · Cited by 12
Vrontaras, N., Myrvali, K., Kyrou, D., Metallidis, S., Tsachouridou, Ο., Chini, M., Meliou, M., Psichοgiou, M., Basoulis, D., Antoniadou, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266962 · Cited by 9
Keane, A. M., & Swartz, T. H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1477845 · Cited by 9
Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes?
Pellicano, C., Leodori, G., Innocenti, G. P., Gigante, A., & Rosato, E. (2019) · Nutrients · doi:10.3390/nu11112629 · Cited by 9
Dunleavy, S., Aidala, A. A., & Yomogida, M. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2019.0086 · Cited by 9
Lopes, S., O’Day, K., Meyer, K. L., van Stiphout, J., Punekar, Y. S., Radford, M., & Haas, J. S. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4928 · Cited by 9
Ascher, S. B., Scherzer, R., Estrella, M. M., Jotwani, V., Shigenaga, J. K., Spaulding, K. A., Ng, D. K., Gustafson, D., Spence, A. B., Sharma, A., et al. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2021.01.012 · Cited by 9
Kubiak, R. W., Kratz, M., Motala, A. A., Galagan, S. R., Govere, S., Brown, E. R., Moosa, M. S., & Drain, P. K. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06473-1 · Cited by 9
Reno, T. A., Tarnus, L., Tracy, R. P., LANDAY, A. L., Sereti, I., Apetrei, C., & Pandrea, I. (2022) · Frontiers in Virology · doi:10.3389/fviro.2021.795373 · Cited by 9
Crane, H. M., & Drumright, L. N. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002836 · Cited by 9
AIDS at 40th: The progress of HIV treatment in Japan
Oka, S. (2022) · Global Health & Medicine · doi:10.35772/ghm.2021.01120 · Cited by 9
Baribeau, V., Kim, C. J., Lorgeoux, R.-P., Brisebois, J., Tossonian, H. K., & Lachaîne, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262645 · Cited by 12
COVID ‐19 hospitalization outcomes in adults by HIV status ; a nation‐wide register‐based study
Möller, I. K., Gisslén, M., Wagner, P., Sparén, P., & Carlander, C. (2023) · HIV Medicine · doi:10.1111/hiv.13515 · Cited by 9
Thudium, R. F., Arentoft, N. S., Hoel, H., Afzal, S., von Stemann, J. H., Forman, J. L., Wilcke, J. T., Benfield, T., Trøseid, M., Borges, Á. H., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad233 · Cited by 9
Hishiya, N., Uno, K., Nakano, A., Konishi, M., Higashi, S., Eguchi, S., Ariyoshi, T., Matsumoto, A., Oka, K., Takahashi, M., et al. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.09.013 · Cited by 9
Grozdeva, R., Ivanov, D. T., Strashimirov, D., Kapincheva, N., Yordanova, R., Mihailova, S. M., Georgieva, A., Alexiev, I., Grigorova, L., Partsuneva, A., et al. (2024) · Viruses · doi:10.3390/v16081205 · Cited by 10
HIV and ageing: what the geriatrician needs to know
Levett, T. J., Wright, J. E., & Fisher, M. (2013) · Reviews in Clinical Gerontology · doi:10.1017/s0959259813000208 · Cited by 10
Eckard, A. R., Thierry-Palmer, M., Silvestrov, N. A., Rosebush, J., O’Riordan, M. A., Daniels, J. E., Uribe-Leitz, M., Labbato, D. E., Ruff, J. H., Singh, R. J., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.01.018 · Cited by 9
Wireless Physical Activity Monitor Use Among Adults Living With HIV: A Scoping Review
Dagenais, M., Cheng, D. K.-Y., Salbach, N. M., Brooks, D., & O’Brien, K. K. (2018) · Rehabilitation Oncology · doi:10.1097/01.reo.0000000000000153 · Cited by 9
Electrocardiographic abnormalities among people with HIV in Shanghai, China
Shen, F., Zhu, B., Ding, Y., Gao, M., & He, N. (2020) · BioScience Trends · doi:10.5582/bst.2020.01013 · Cited by 9
Savinelli, S., Francesco, D. D., Feeney, E. R., Babalis, D. S., Bagkeris, E., Post, F. A., Boffito, M., Williams, I. G., Vera, J. H., Johnson, M. A., et al. (2020) · HIV Medicine · doi:10.1111/hiv.12857 · Cited by 9
Johnston, C. D., Siegler, E. L., Rice, M. C., Derry, H. M., Hootman, K. C., Zhu, Y., Burchett, C. O., Gupta, S. K., Choi, M. E., & Glesby, M. J. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002766 · Cited by 9
So Pathogenic or So What?—A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research
Kleinman, A. J., Pandrea, I., & Apetrei, C. (2022) · Viruses · doi:10.3390/v14010135 · Cited by 11
Venturas, J. P. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1758852 · Cited by 9
Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study
Lake, J. E., Seang, S., Kelesidis, T., Liao, D. H., Hodis, H. N., Stein, J. H., & Currier, J. S. (2015) · HIV Clinical Trials · doi:10.1179/1945577115y.0000000006 · Cited by 9
Comparative Risk of Fracture in Men and Women with HIV
Gedmintas, L., Wright, E. A., Losina, E., Katz, J. N., & Solomon, D. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2194 · Cited by 9
Gray, L., Chalabaëv, A., Durant, J., Rosenthal, É., Pradier, C., Duracinský, M., Rouanet, I., Schuft, L., Colson, S. S., & d’Arripe-Longueville, F. (2018) · Archives of Public Health · doi:10.1186/s13690-018-0269-1 · Cited by 9
Dragović, G., Andjić, M., Toljić, B., Jevtović, D., Lukić, R., Luka, S. R. D., Trbovich, A. M., & Milašin, J. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111269 · Cited by 9
Hentzien, M., Delpierre, C., Puglièse, P., Allavena, C., Jacomet, C., Valantin, M., Cabie, A., Cuzin, L., Rey, D., Bani‐Sadr, F., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195725 · Cited by 10
Pereira, B. I., Mazzitelli, M., Milinkovic, A., Moyle, G., Mandalia, S., Al-hussaini, A., & Boffito, M. (2021) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2021.0064 · Cited by 8
Aminde, J. A., Burton, N. W., Thng, C., & Clanchy, K. (2024) · Preventive Medicine · doi:10.1016/j.ypmed.2024.108144 · Cited by 8
Estimation of Lifetime Costs Among Insured Persons with HIV in the United States
Cohen, J., Anupindi, V. R., Doshi, R., Yeaw, J., Zhou, X., Christoph, M. J., Chen, M., Chaudhari, P., Trom, C., & Zachry, W. (2025) · PharmacoEconomics - Open · doi:10.1007/s41669-025-00584-0 · Cited by 8
Fombellida-Lopez, C., Ortmans, D. A., Moutschen, M. P., Pasternak, A. O., & Darcis, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1628086 · Cited by 8
HIV and Aging – Perhaps Not as Dramatic as We Feared?
Engel, T., Raffenberg, M., Marzolini, C., Cavassini, M. L., Kovari, H., Hasse, B. K., & TARR, P. E. (2018) · Gerontology · doi:10.1159/000489172 · Cited by 8
Older Persons with HIV in Canada
Sok, P. (2019) · Journal of Infectious Diseases and Epidemiology · doi:10.23937/2474-3658/1510084 · Cited by 8
Managing cardiovascular risk in people living with HIV in Asia – where are we now?
Choi, J. Y., Lui, G. C.-Y., Liao, C., & Yang, C. (2021) · HIV Medicine · doi:10.1111/hiv.13164 · Cited by 8
Patient outcomes in integrated HIV and non-communicable disease models of care: a scoping review
Gausi, B., Kuodi, P., Jacob, N., & Oni, T. (2021) · Journal of Global Health Reports · doi:10.29392/001c.27094 · Cited by 8
Mohammed, S., Qrareya, A. N., Mahdi, F., Moss, E. M., Akins, N. S., Li, J., Le, H. V., & Paris, J. J. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13047 · Cited by 9
Alsayed, H. A. H., Sharif‐Askari, N. S., & Rahimi, M. R. (2022) · Medicine and Pharmacy Reports · doi:10.15386/mpr-2305 · Cited by 8
Scanlan, A., Zhang, Z., Koneru, R., Reece, M. D., Gavegnano, C., Anderson, A. M. L., & Tyor, W. R. (2022) · Microorganisms · doi:10.3390/microorganisms10112244 · Cited by 8
The role of extracellular ATP and P2X receptors in the pathogenesis of HIV-1
Rodriguez, N., Fortune, T., Vuong, T., & Swartz, T. H. (2023) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2023.102358 · Cited by 8
Zandt, A. R. V., & MacLean, A. G. (2023) · Journal of NeuroVirology · doi:10.1007/s13365-023-01162-y · Cited by 9
Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV
Alvarez, J. A., Yang, C.-A., Ojuri, V., Buckley, K., Bedi, B., Musonge-Effoe, J., Soibi-Harry, A. P., & Lahiri, C. D. (2024) · Current HIV/AIDS Reports · doi:10.1007/s11904-024-00711-2 · Cited by 8
Factors related to NT-proBNP levels in HIV patients aged over 40 years
Olalla, J., Crespo, E., Lima, J. D. L. T., Sempere, M., del Arco, A., Prada, J. L., Malvarez, R., Pérez, J., & García‐Alegría, J. (2015) · AIDS Research and Therapy · doi:10.1186/s12981-015-0058-7 · Cited by 8
Masiá, M., Bernal, E., Robledano, C., Padilla, S., López, N., Martínez, E., & Gutiérrez, F. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku269 · Cited by 8
People Living With HIV: Implications for Rehabilitation Nurses
Perazzo, J. D., Webel, A. R., McGough, E. L., & Voss, J. G. (2016) · Rehabilitation Nursing · doi:10.1002/rnj.310 · Cited by 8
Increasing procoagulant activity of circulating microparticles in patients living with HIV
Snopková, S., Matýšková, M., Havlíčková, K., Jarkovský, J., Svoboda, M., Zavřelová, J., Svačinka, R., Penka, M., & Husa, P. (2019) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2019.09.013 · Cited by 8
Baynes, H. W., Negash, M., Geremew, D., & Getaneh, Z. (2019) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.275462 · Cited by 8
Costaggiu, D., Pinna, E., Serchisu, L., Barcellona, D., Piano, P., Ortu, F., Marongiu, F., & Mandas, A. (2020) · AIDS Care · doi:10.1080/09540121.2020.1742859 · Cited by 8
Lemma, M., Petkov, S., Bekele, Y., Petros, B., Howe, R., & Chiodi, F. (2020) · Proteomes · doi:10.3390/proteomes8030024 · Cited by 8
Arant, E. C., Harding, C., Geba, M. C., Targonski, P. V., & McManus, K. A. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa584 · Cited by 9
Marin, R.-C., Ţiţ, D. M., Săndulescu, O., Streinu‐Cercel, A., & BUNGAU, S. G. (2021) · Biomedicines · doi:10.3390/biomedicines9080987 · Cited by 8
Paz, G. A., Farinatti, P., Lopes, K. G., & Borges, J. P. (2021) · HIV Research & Clinical Practice · doi:10.1080/25787489.2021.1979727 · Cited by 8
Buju, R. T., Akilimali, P. Z., Tran, N. T., Kamangu, E. N., Kahunu, G. M., Kayembe, J. M., & Situakibanza, H. N.-T. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610220 · Cited by 8
Rodrigue, J. R., Paek, M. J., Egbuna, O. I., Waterman, A. D., Pavlakis, M., & Mandelbrot, D. A. (2013) · Transplantation · doi:10.1097/tp.0b013e318282f282 · Cited by 8
Flexor, G., Zucman, D., Berthé, H., Meier, F., Force, G., Greder-Belan, A., Billy, C., Dupont, C., Mortier, E., Bizard, A., et al. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2012.11.005 · Cited by 8
Study design issues in evaluating immune biomarkers
Bosch, R. J., Zhang, X., & Utay, N. S. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835d3259 · Cited by 8
Rasmussen, L. D., Kronborg, G., Larsen, C. S., Pedersen, C., Gerstoft, J., Obel, N., & Pottegård, A. (2016) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2016.1212168 · Cited by 8
Tasca, K. I., Caleffi, J. T., Corrêa, C. R., Gatto, M., de Camargo, C. C., Mendes, M. B., Golim, M. D. A., Biasin, M., & de Souza, L. D. R. (2016) · Mediators of Inflammation · doi:10.1155/2016/2909576 · Cited by 8
Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
Mocroft, A., Laut, K. G., Reiss, P., Gatell, J. M., Ormaasen, V., Cavassini, M. L., Hadžiosmanović, V., Mansinho, K., Pradier, C., Vasylyev, M., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001684 · Cited by 8
Tan, J. Y., Nguyen, T. T., Tabrisky, A. P., Siedle-Khan, R., & Nápoles, A. M. (2018) · JMIR Aging · doi:10.2196/11723 · Cited by 8
New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment
Angelovich, T. A., Churchill, M. J., Wright, E., & Brew, B. J. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_126 · Cited by 8
Santos, M. E., Protopopescu, C., Ribero, R. A., Benzaken, A. S., Pereira, G. F. M., Stevens, A., Nishimwe, M. L., Yaya, I., Carrieri, P., & de Araújo, W. N. (2020) · AIDS · doi:10.1097/qad.0000000000002621 · Cited by 8
Walmsley, S. L., Clarke, R., Lee, T., Singer, J., Cheung, A. M., Smaill, F., de Pokomandy, A., Trottier, S., Messina, E., & Guaraldi, G. (2022) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2022.0106 · Cited by 8
Self-citationBellasi, A., Raggi, P., Rossi, R., Rochira, V., Stentarelli, C., Zona, S., Lattanzi, A., Carli, F., Mussini, C., & Guaraldi, G. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.017 · Cited by 8
Self-citationCattaneo, D., & Gervasoni, C. (2017) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-016-0394-6 · Cited by 8
The transition from co-morbidities to geriatric syndromes in HIV
Guaraldi, G. (2016) · GERMS · doi:10.11599/germs.2016.1092 · Cited by 8
Self-citationYang, N. Y., Hsieh, A. Y. Y., Chen, Z., Campbell, A. R., Gadawska, I., Kakkar, F., Sauve, L. J., Bitnun, A., Brophy, J. C., Murray, M. C. M., et al. (2024) · Viruses · doi:10.3390/v16050755 · Cited by 8
Saumoy, M., Fernández, A., Tiraboschi, J. M., Peñafiel, J., Sánchez‐Quesada, J. L., Vega, J., García, B., Soriano, I., Podzamczer, D., & Imaz, A. (2025) · HIV Medicine · doi:10.1111/hiv.70017 · Cited by 7
Projected Increases in Older People With HIV in the United States Through 2040
O’Connor, S., Song, R., Viguerie, A., Buchacz, K. A., Lyles, C. M., Farnham, P. G., Grytdal, S., Hutchinson, A. B., Byrd, K. K., & Brooks, J. T. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf656 · Cited by 7
Yeşilbağ, Z., Şengül, E. İ., Şenoğlu, S., Aydın, Ö. A., & Karaosmanoğlu, H. K. (2020) · Current HIV Research · doi:10.2174/1574885515666200812215140 · Cited by 7
Factors associated with early biological aging in older people with HIV
Peixoto, I. R., de Melo, L. S. W., & Lacerda, H. R. (2022) · AIDS Care · doi:10.1080/09540121.2022.2091103 · Cited by 7
Prevalence of and factors associated with diabetes mellitus among people living with HIV in Vietnam
Nagai, M., Matsumoto, S., Tanuma, J., Nguyen, D. H. T., Nguyen, D. T., Mizushima, D., Oka, S., & Pham, T. N. (2023) · Global Health & Medicine · doi:10.35772/ghm.2022.01061 · Cited by 7
Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV
Qing, Y., Chan, R., Fu, P., Cullen, J., Miron, A., Jacobson, J. M., Pink, J. J., & Gerson, S. L. (2023) · Cancer Medicine · doi:10.1002/cam4.5809 · Cited by 7
Penner, J. A., Ombajo, L. A., Otieno, D. O., Nkuranga, J., Mburu, M., Wahome, S., Pozniak, A., & Bhagani, S. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285787 · Cited by 7
Fradejas, J. F., Delgado‐Silveira, E., González‐Burgos, E., Álvarez‐Díaz, A. M., & Vélez‐Díaz‐Pallarés, M. (2024) · HIV Medicine · doi:10.1111/hiv.13616 · Cited by 7
Colson, A. E., Chastek, B. J., Gruber, J., Majethia, S., Zachry, W., Mezzio, D. J., Rock, M., Anderson, A. J., & Cohen, J. (2024) · Future Virology · doi:10.1080/17460794.2024.2403246 · Cited by 7
Stuart, L., Alford, K. A., & Vera, J. H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0314185 · Cited by 7
Individualizing Antiretroviral Therapy in the Older Patient
Hoy, J. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01168-z · Cited by 7
Vance, D. E. (2013) · ISRN Nursing · doi:10.1155/2013/297173 · Cited by 8
Considerations for the Long-Term Management of Women Living with HIV in Europe
Dominguez, S., Branco, T. L., & Haruperi, T. (2012) · Antiviral Therapy · doi:10.3851/imp2639 · Cited by 7
Reduced neural specificity in middle-aged HIV+ women in the absence of behavioral deficits
Liu, C., Wang, C., Leclair, M., Young, M., & Jiang, X. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.12.003 · Cited by 7
Schoffelen, A. F., Smit, C., van Lelyveld, S. F. L., Vogt, L., Bauer, M. P., Reiss, P., Hoepelman, A. I. M., & Barth, R. E. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv026 · Cited by 7
Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults
Sakoda, M., Fazeli, P. L., Ellis, R. J., Jeste, D. V., Grant, I., Letendre, S. L., & Moore, D. J. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001235 · Cited by 8
Funke, B., Spinner, C., Esser, S., Stellbrink, H. J., Stoehr, A. D., Wolf, E., Koegl, C., Bruening, J., & Witte, A. V. (2020) · International Journal of STD & AIDS · doi:10.1177/0956462420959169 · Cited by 7
Metadata
- Authors
- Guaraldi, G., Orlando, G., Zona, S., Menozzi, M., Carli, F., Garlassi, E., Berti, A., Rossi, E., Roverato, A., & Palella, F.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- Cineca (IT)
- University of Bologna (IT)
- Northwestern University (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-10-13
- Volume
- 53
- Issue
- 11
- Pages
- 1120-1126
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2135397849
- Cited by
- 1,331
- References
- 31
- Citations by year
- 2026: 63 · 2025: 72 · 2024: 96 · 2023: 84 · 2022: 89 · 2021: 122 · 2020: 119 · 2019: 117 · 2018: 131 · 2017: 100 · 2016: 92 · 2015: 66 · 2014: 79 · 2013: 55 · 2012: 38
- FWCI
- 65.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV infection, age-related comorbidities, cardiovascular disease, hypertension, diabetes mellitus, bone fractures, renal failure, antiretroviral therapy, risk factors, comorbidity screening
- MeSH terms
- Adult, Age Factors, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Hypertension, Italy, Male, Middle Aged, Risk Factors, HIV Infections, Comorbidity, Prevalence, Case-Control Studies, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Fractures, Bone, Renal Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review